Skip to main content
OpenTrials
Completed

NCT Number: NCT03872362

Radiomics Multifactorial Biomarker for Pulmonary Nodules

The investigators aim to investigate the utility of radiomics to differentiate malignant nodules from benign nodules and invasive adenocarcinoma from non-invasive adenocarcinoma.

Completed

Looking for future studies?

Notify Me

Key information

About this study

With the development of computed tomography (CT) equipment and the increasing use of lung cancer screening programs with low-dose CT, a growing number of early-stage lung cancers were detected so that a large number of patients have undergone surgery.

Although a number of radiological studies have been used morphological signs so-called semantic features to make a differential diagnosis, it is still hard to apply by clinician because pulmonary nodules especially ground-glass nodules and small size nodules have atypical radiology signs and have strong subjectivity from different observers. Recently, CT-based radiomics, extracting the quantitative high-throughput features from medical images and facilitating clinical decision-making system, showed a good performance to predict diagnosis and prognosis of diverse cancer.

Therefore, the proposed project aims to develop and validate radiomics models based on CT images to identify malignant nodules and then to discriminate the different types of lung adenocarcinoma in patients with pulmonary nodules.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • intraoperative frozen section diagnosis and final pathology diagnosis are available
  • preoperative standard non-enhanced CT is available
  • Pathologically confirmed

Exclusion criteria

  • with a previous history of radiation therapy, chemotherapy or biopsy
  • the time interval between the CT examination and surgery was more than two weeks

Treatment and study plan

radiomics

Diagnostic Test

The high-throughput extraction of large amounts of quantitative image features from medical images

Primary outcomes

  1. Malignant nodules classifier

    Time frame: 30 days

    Model based on Radiomic that can differentiate malignant nodules from benign nodules.

  2. Invasive adenocarcinoma classifier

    Time frame: 30 days

    Model based on Radiomic that can differentiate invasive adenocarcinoma from non-invasive adenocarcinoma.

Sponsors and collaborators

Lead sponsor

Maastricht University

Other

Collaborators

  • Affiliated Zhongshan Hospital of Dalian University
  • The Fifth Hospital of Dalian
  • The Second Affiliated Hospital of Dalian Medical University

Registry information

Official study title

Radiomics and Clinical Variables Can Differentiate Malignant Nodules and Detect Invasive Adenocarcinoma in Pulmonary Nodules: a Multi-center Study

Acronym: RMBPN

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Mar 13, 2019
Registry last updated
Mar 13, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.